Print

Brainsway (BRSYF.PK) Release: Multiple Sclerosis Clinical Trial - Final Results  
11/14/2012 7:41:57 AM

JERUSALEM, Nov. 13, 2012 (GLOBE NEWSWIRE) -- Further to that stated in Brainsway's (TASE:BRIN) periodic report for 2011 regarding the double-blind clinical trial being conducted at the Charité Hospital in Berlin and at the University Medical Center Hamburg-Eppendorf in Hamburg to assess the safety and efficacy of the Company's Deep TMS device for the treatment of fatigue and depression symptoms in multiple sclerosis (MS) patients, the Company is pleased to announce the final results of the trial.